These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3279906)

  • 21. In vitro activity of tigemonam against urinary tract pathogens.
    Garcia-Rodriguez JA; Garcia-Sanchez JE
    J Chemother; 1989 May; 1 Suppl 2():28-31. PubMed ID: 2809699
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro antibacterial activity and beta-lactamase stability of E-0702, a new cephalosporin.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1983 Sep; 24(3):313-20. PubMed ID: 6605718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2003 Oct; 56(5):458-96. PubMed ID: 14692381
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In-vitro activity of tigemonam, an oral monobactam, against gram-negative rods, including variants in beta-lactamase-production.
    Brown J; Yang YJ; Livermore DM
    J Antimicrob Chemother; 1989 Feb; 23(2):201-7. PubMed ID: 2785102
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of a new cephalosporin ME-1206 compared with other agents.
    Chin NX; Zhang YX; Neu HC
    Diagn Microbiol Infect Dis; 1991; 14(5):417-24. PubMed ID: 1797456
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of aztreonam against gram negative bacteria from clinical specimens and its comparison with other commonly used antibiotics.
    Qadri SM; Belobraydic KA
    Methods Find Exp Clin Pharmacol; 1986 Apr; 8(4):223-6. PubMed ID: 3088346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro activity of Ro 09-1428 compared to other cephalosporins.
    Chin NX; Gu JW; Fang W; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):669-75. PubMed ID: 1748124
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
    Neu HC; Chin NX; Jules K; Labthavikul P
    J Antimicrob Chemother; 1986 Apr; 17(4):441-52. PubMed ID: 3486862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
    Yu KW; Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity and beta-lactamase stability of FK-037, a parenteral cephalosporin.
    Neu HC; Chin NX; Huang HB
    Antimicrob Agents Chemother; 1993 Mar; 37(3):566-73. PubMed ID: 8460925
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Post-marketing surveillance of antibacterial activities of cefozopran against various clinical isolates--II. Gram-negative bacteria].
    Igari J; Oguri T; Hiramatsu N; Akiyama K; Koyama T
    Jpn J Antibiot; 2002 Feb; 55(1):22-60. PubMed ID: 11977920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro studies of tigemonam: a comparison of the minimum inhibitory and minimum bactericidal concentrations (MIC vs MBC).
    Gobernado M; Cantón E
    J Chemother; 1989 May; 1 Suppl 2():36-40. PubMed ID: 2809701
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The in vitro activity of tigemonam: a comparison with other antimicrobial agents.
    Andrews JM; Wise R
    J Chemother; 1989 May; 1 Suppl 2():5-12. PubMed ID: 2509645
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro activity and beta-lactamase stability of a new difluoro oxacephem, 6315-S.
    Neu HC; Chin NX
    Antimicrob Agents Chemother; 1986 Nov; 30(5):638-44. PubMed ID: 3492172
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro activity and beta-lactamase stability of cefmenoxime.
    Neu HC; Labthavikul P
    Antimicrob Agents Chemother; 1982 Aug; 22(2):316-22. PubMed ID: 6100427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibacterial activity in vitro of tigemonam, a new oral monobactam.
    Schito GC; Debbia E; Bandelloni R; Paglia P; Pesce A
    J Chemother; 1989 May; 1 Suppl 2():41-4. PubMed ID: 2809702
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The activity of cefbuperazone, a 7 alpha-methoxy 7 beta acyl ureido cephalosporin.
    Neu HC; Chin NX; Labthavikul P
    Chemioterapia; 1985 Dec; 4(6):415-23. PubMed ID: 3879464
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibacterial activity and beta-lactamase stability of MDL 19,592, an oral cephalosporin.
    Yu KW; Neu HC
    Diagn Microbiol Infect Dis; 1989; 12(5):441-3. PubMed ID: 2515027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antimicrobial activity and beta-lactamase stability of SK&F 88070 compared with other agents.
    Neu HC; Chin NX; Labthavikul P
    Diagn Microbiol Infect Dis; 1986 Mar; 4(3):223-30. PubMed ID: 3485506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.